Celldex Therapeutics Shares Resumed Trade
Portfolio Pulse from Benzinga Newsdesk
Celldex Therapeutics shares have resumed trading after a temporary halt. This development may influence investor sentiment and trading activity in the short term.
September 25, 2024 | 3:09 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Celldex Therapeutics shares have resumed trading after a temporary halt, which could lead to increased volatility and investor interest in the short term.
The resumption of trading in Celldex Therapeutics shares after a halt can lead to increased volatility as investors react to the news. The impact on the stock price will depend on the reasons behind the halt and subsequent investor sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100